Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 915,527 | 943,630 | 900,195 | 828,568 | 841,661 |
| Cost of Goods | 367,545 | 370,780 | 357,224 | 343,641 | 335,035 |
| Gross Profit | 547,982 | 572,850 | 542,971 | 484,927 | 506,626 |
| Operating Expenses | 273,244 | 277,486 | 262,796 | 259,041 | 261,833 |
| Operating Income | 275,283 | 296,144 | 280,399 | 226,527 | 244,828 |
| Interest Expense | 8,647 | 10,542 | 13,127 | 13,547 | 10,998 |
| Other Income | 1,255 | 327 | 416 | 235 | 353 |
| Pre-tax Income | 267,891 | 285,929 | 267,688 | 213,215 | 234,183 |
| Income Tax | 55,660 | 61,693 | 53,634 | 41,008 | 53,245 |
| Net Income Continuous | 212,231 | 224,236 | 214,054 | 172,207 | 180,938 |
| Net Income | $212,231 | $224,236 | $214,054 | $172,207 | $180,938 |
| EPS Basic Total Ops | 2.55 | 2.70 | 2.58 | 2.08 | 2.17 |
| EPS Basic Continuous Ops | 2.55 | 2.70 | 2.58 | 2.08 | 2.17 |
| EPS Diluted Total Ops | 2.53 | 2.67 | 2.55 | 2.05 | 2.15 |
| EPS Diluted Continuous Ops | 2.53 | 2.67 | 2.55 | 2.05 | 2.15 |
| EBITDA(a) | $304,268 | $323,999 | $308,730 | $255,247 | $273,375 |